ReP USP - Resultado da busca

Artigo de periodico
Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis (2021)
Ortega, Juliana Festa; Heidor, Renato ; Auriemo, Ana Paula; Affonso, Juliana Marques; D’Amico, Thais; Herz, Corinna; Conti, Aline de ; Ract, Juliana Neves Rodrigues ; Gioielli, Luiz Antonio ; Purgatto, Eduardo ; Lamy, Evelyn; Pogribny, Igor; Moreno, Fernando Salvador
Fonte: Carcinogenesis. Unidade: FCF
Assuntos: LIPÍDEOS, DANO AO DNA, CARCINOGÊNESE, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORTEGA, Juliana Festa et al. Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis. Carcinogenesis, v. 42, n. 8, p. 1026–1036, 2021Tradução . . Disponível em: https://doi.org/10.1093/carcin/bgab039. Acesso em: 19 nov. 2024.
APA
Ortega, J. F., Heidor, R., Auriemo, A. P., Affonso, J. M., D’Amico, T., Herz, C., et al. (2021). Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis. Carcinogenesis, 42( 8), 1026–1036. doi:10.1093/carcin/bgab039
NLM
Ortega JF, Heidor R, Auriemo AP, Affonso JM, D’Amico T, Herz C, Conti A de, Ract JNR, Gioielli LA, Purgatto E, Lamy E, Pogribny I, Moreno FS. Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis [Internet]. Carcinogenesis. 2021 ; 42( 8): 1026–1036.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/carcin/bgab039
Vancouver
Ortega JF, Heidor R, Auriemo AP, Affonso JM, D’Amico T, Herz C, Conti A de, Ract JNR, Gioielli LA, Purgatto E, Lamy E, Pogribny I, Moreno FS. Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis [Internet]. Carcinogenesis. 2021 ; 42( 8): 1026–1036.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/carcin/bgab039
Artigo de periodico
Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis (2020)
Conti, Aline de ; Tryndyak, Volodymyr ; Heidor, Renato ; Jimenez, Leandro; Moreno, Fernando Salvador ; Beland, Frederick A ; Rusyn, Ivan; Pogribny, Igor P
Fonte: Journal of Nutritional Biochemistry. Unidade: FCF
Assuntos: LIPÍDEOS, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONTI, Aline de et al. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis. Journal of Nutritional Biochemistry, v. 86, p. 1-9 art. 108496, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jnutbio.2020.108496. Acesso em: 19 nov. 2024.
APA
Conti, A. de, Tryndyak, V., Heidor, R., Jimenez, L., Moreno, F. S., Beland, F. A., et al. (2020). Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis. Journal of Nutritional Biochemistry, 86, 1-9 art. 108496. doi:10.1016/j.jnutbio.2020.108496
NLM
Conti A de, Tryndyak V, Heidor R, Jimenez L, Moreno FS, Beland FA, Rusyn I, Pogribny IP. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis [Internet]. Journal of Nutritional Biochemistry. 2020 ; 86 1-9 art. 108496.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.jnutbio.2020.108496
Vancouver
Conti A de, Tryndyak V, Heidor R, Jimenez L, Moreno FS, Beland FA, Rusyn I, Pogribny IP. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis [Internet]. Journal of Nutritional Biochemistry. 2020 ; 86 1-9 art. 108496.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.jnutbio.2020.108496
Artigo de periodico
β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats (2019)
Miranda, Mayara Lilian Paulino; Furtado, Kelly Silva; Andrade, Fábia de Oliveira; Heidor, Renato ; Cruz, Raquel Santana da; Nogueira, Marina Sayuri; Castro, Inar Alves de ; Purgatto, Eduardo ; Barbisan, Luis Fernando ; Moreno, Fernando Salvador
Fonte: Chemico Biological Interactions. Unidade: FCF
Assuntos: CARCINOGÊNESE, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Mayara Lilian Paulino et al. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats. Chemico Biological Interactions, v. 308, p. 377-384, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2019.05.046. Acesso em: 19 nov. 2024.
APA
Miranda, M. L. P., Furtado, K. S., Andrade, F. de O., Heidor, R., Cruz, R. S. da, Nogueira, M. S., et al. (2019). β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats. Chemico Biological Interactions, 308, 377-384. doi:10.1016/j.cbi.2019.05.046
NLM
Miranda MLP, Furtado KS, Andrade F de O, Heidor R, Cruz RS da, Nogueira MS, Castro IA de, Purgatto E, Barbisan LF, Moreno FS. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats [Internet]. Chemico Biological Interactions. 2019 ; 308 377-384.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cbi.2019.05.046
Vancouver
Miranda MLP, Furtado KS, Andrade F de O, Heidor R, Cruz RS da, Nogueira MS, Castro IA de, Purgatto E, Barbisan LF, Moreno FS. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats [Internet]. Chemico Biological Interactions. 2019 ; 308 377-384.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cbi.2019.05.046
Artigo de periodico
Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis (2019)
Andrade, Fábia de Oliveira; Furtado, Kelly Silva ; Heidor, Renato ; Sandri, Silvana; Hebeda, Cristina Bichels ; Miranda, Mayara Lilian Paulino; Fernandes, Laura Helena Gasparini; Yamamoto, Roberto Carvalho; Horst, Maria Aderuza; Farsky, Sandra Helena Poliselli ; Moreno, Fernando Salvador
Fonte: Carcinogenesis. Unidade: FCF
Assuntos: CARCINOMA HEPATOCELULAR, CARCINOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Fábia de Oliveira et al. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis. Carcinogenesis, v. 40, n. 8, p. 979-988, 2019Tradução . . Disponível em: https://doi.org/10.1093/carcin/bgy190. Acesso em: 19 nov. 2024.
APA
Andrade, F. de O., Furtado, K. S., Heidor, R., Sandri, S., Hebeda, C. B., Miranda, M. L. P., et al. (2019). Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis. Carcinogenesis, 40( 8), 979-988. doi:10.1093/carcin/bgy190
NLM
Andrade F de O, Furtado KS, Heidor R, Sandri S, Hebeda CB, Miranda MLP, Fernandes LHG, Yamamoto RC, Horst MA, Farsky SHP, Moreno FS. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis [Internet]. Carcinogenesis. 2019 ; 40( 8): 979-988.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/carcin/bgy190
Vancouver
Andrade F de O, Furtado KS, Heidor R, Sandri S, Hebeda CB, Miranda MLP, Fernandes LHG, Yamamoto RC, Horst MA, Farsky SHP, Moreno FS. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis [Internet]. Carcinogenesis. 2019 ; 40( 8): 979-988.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/carcin/bgy190
Artigo de periodico
Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents (2016)
Moreno, Fernando Salvador ; Heidor, Renato ; Pogribny, Igor P
Fonte: Nutrition and Cancer. Unidade: FCF
Assuntos: CARCINOMA HEPATOCELULAR, NUTRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Fernando Salvador e HEIDOR, Renato e POGRIBNY, Igor P. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutrition and Cancer, v. 68, n. 5, p. 719-733, 2016Tradução . . Disponível em: https://doi.org/10.1080/01635581.2016.1180410. Acesso em: 19 nov. 2024.
APA
Moreno, F. S., Heidor, R., & Pogribny, I. P. (2016). Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutrition and Cancer, 68( 5), 719-733. doi:10.1080/01635581.2016.1180410
NLM
Moreno FS, Heidor R, Pogribny IP. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents [Internet]. Nutrition and Cancer. 2016 ; 68( 5): 719-733.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1080/01635581.2016.1180410
Vancouver
Moreno FS, Heidor R, Pogribny IP. Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents [Internet]. Nutrition and Cancer. 2016 ; 68( 5): 719-733.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1080/01635581.2016.1180410
Trabalho de evento-resumo periodico
Chemopreventive effect of tributyrin during hepatocarcinogenesis associated to the development of steatosis in rats (2016)
Yamamoto, Roberto; Heidor, Renato ; Moreno, Fernando Salvador
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMAMOTO, Roberto e HEIDOR, Renato e MORENO, Fernando Salvador. Chemopreventive effect of tributyrin during hepatocarcinogenesis associated to the development of steatosis in rats. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 19 nov. 2024. , 2016
APA
Yamamoto, R., Heidor, R., & Moreno, F. S. (2016). Chemopreventive effect of tributyrin during hepatocarcinogenesis associated to the development of steatosis in rats. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Yamamoto R, Heidor R, Moreno FS. Chemopreventive effect of tributyrin during hepatocarcinogenesis associated to the development of steatosis in rats. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 39 res. FCF073.[citado 2024 nov. 19 ]
Vancouver
Yamamoto R, Heidor R, Moreno FS. Chemopreventive effect of tributyrin during hepatocarcinogenesis associated to the development of steatosis in rats. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 39 res. FCF073.[citado 2024 nov. 19 ]
Artigo de periodico
The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis (2016)
Heidor, Renato ; Conti, Aline de; Ortega, Juliana Festa; Furtado, kelly Silva; Silva, Roberta C; Tavares, Paulo Eduardo latorre; Purgatto, Eduardo ; Ract, Juliana Neves Rodrigues ; Paiva, Sérgio Alberto Rupp de; Gioielli, Luiz Antonio ; Pogribny, Igor P; Moreno, Fernando Salvador
Fonte: Molecular Nutrition Food Research. Unidade: FCF
Assuntos: NUTRIÇÃO EXPERIMENTAL, CARCINOGÊNESE ANIMAL, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEIDOR, Renato et al. The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis. Molecular Nutrition Food Research, v. 60, p. 420-429, 2016Tradução . . Disponível em: https://doi.org/10.1002/mnfr.201500643. Acesso em: 19 nov. 2024.
APA
Heidor, R., Conti, A. de, Ortega, J. F., Furtado, kelly S., Silva, R. C., Tavares, P. E. latorre, et al. (2016). The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis. Molecular Nutrition Food Research, 60, 420-429. doi:10.1002/mnfr.201500643
NLM
Heidor R, Conti A de, Ortega JF, Furtado kelly S, Silva RC, Tavares PE latorre, Purgatto E, Ract JNR, Paiva SAR de, Gioielli LA, Pogribny IP, Moreno FS. The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis [Internet]. Molecular Nutrition Food Research. 2016 ; 60 420-429.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1002/mnfr.201500643
Vancouver
Heidor R, Conti A de, Ortega JF, Furtado kelly S, Silva RC, Tavares PE latorre, Purgatto E, Ract JNR, Paiva SAR de, Gioielli LA, Pogribny IP, Moreno FS. The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis [Internet]. Molecular Nutrition Food Research. 2016 ; 60 420-429.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1002/mnfr.201500643

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Grupo de pesquisa

Afiliação dos autores externos não normalizada